data13F

IMVT – Immunovant Inc

Held by 1 of 60 tracked investors in their latest 13F filing

Investors holding1
Combined shares70,140
Combined reported value$2.4M

IMVT chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
David Einhorn 0.07 Reduced 25.0%70,140$2.4MQ3 2026
Paul Tudor Jones0.00Closed0–Q3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026David Einhorn Reduced 25.0%70,1400.02
Q3 2026Paul Tudor Jones narrow view Closed00.01
Q2 2026Paul Tudor Jones narrow view New57,1450.01
Q1 2026David Einhorn New93,5200.07
Q1 2026Paul Tudor Jones narrow view Closed00.00
Q4 2025Paul Tudor Jones narrow view Reduced 71.8%25,6000.01

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q2 2026Paul Tudor Jones narrow view New57,1450.01
Q1 2026David Einhorn New93,5200.07

Reduced: reduced or closed

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026David Einhorn Reduced 25.0%70,1400.02
Q3 2026Paul Tudor Jones narrow view Closed00.01
Q1 2026Paul Tudor Jones narrow view Closed00.00
Q4 2025Paul Tudor Jones narrow view Reduced 71.8%25,6000.01

History

2 peakQ3 2026: 1 tracked investors
Q1 2023: 1 tracked investorsQ2 2023: 1 tracked investorsQ3 2023: 1 tracked investorsQ4 2023: 2 tracked investorsQ1 2024: 1 tracked investorsQ3 2025: 1 tracked investorsQ4 2025: 1 tracked investorsQ1 2026: 1 tracked investorsQ2 2026: 2 tracked investorsQ3 2026: 1 tracked investors
20232026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
David Einhorn70.1K93.5K93.5K–––––
Paul Tudor Jones–57.1K–25.6K90.8K–––

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).